Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTHEM-UC
NCT06049017Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2023
- Primary completion
- Sep 2024
- Modality
- Peptides, Small Molecules
- Countries
- 21
01
Overview
A Phase 2 trial of icotrokinra in ulcerative colitis (UC), sponsored by Janssen Pharmaceutical. Started Oct 2023; status: completed.
02
Drugs
icotrokinra
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06049017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06049017.